Freddie Mac Names Kenny M. Smith as Next Chief Executive
WSJ· 2025-12-16 19:38
Smith is expected to start the role on Wednesday and would also serve as a board member, the government-backed mortgage provider said. ...
Safran: I Went 'Hold' Too Early, But It's Overvalued Now (OTCMKTS:SAFRY)
Seeking Alpha· 2025-12-16 19:37
It's time for me to update my thesis on Safran SA ( SAFRY ). This is unfortunately one of those companies where I went "Hold" too early. Remember, however, that I rated Safran a "Buy" long before it went here. So, evenAnalyst’s Disclosure:I/we have a beneficial long position in the shares of EADSY either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no busin ...
Kevin Hassett regains lead over Kevin Warsh on prediction markets in neck-and-neck Fed chairman race
New York Post· 2025-12-16 19:37
Kevin Hassett and Kevin Warsh are in a neck-and-neck race for the next chairman of the Federal Reserve – with the lead changing hands on prediction markets several times this week.Hassett, director of the National Economic Council, regained the top spot on Kalshi and Polymarket on Tuesday as he pleaded his case for the job.The Fed’s “independence is really, really important, and the voices of the other people at the [Federal Open Market Committee], they’re important, too,” Hassett told CNBC on Tuesday.Kevin ...
Why Is Monte Rosa Stock Trading Higher Today?
Benzinga· 2025-12-16 19:37
Monte Rosa Therapeutics Inc. (NASDAQ:GLUE) shared interim data from an ongoing Phase 1/2 clinical study evaluating MRT-2359 in combination with enzalutamide in heavily pretreated patients with metastatic castration-resistant prostate cancer (mCRPC).The Phase 1/2 study evaluated 0.5 mg and 0.75 mg of MRT-2359 administered orally on a 21-days-on, 7-day-off drug schedule in combination with Pfizer Inc. (NYSE:PFE) and Astellas Pharma Inc.’s (OTC:ALPMF) (OTC:ALPMY) Xtandi (enzalutamide).The study population, as ...
Bank of America (BAC) Target Cut at Morgan Stanley on Earnings Revisions
Yahoo Finance· 2025-12-16 19:36
Bank of America Corporation (NYSE:BAC) is included among the 15 Best Blue-Chip Stocks with Growing Dividends. Bank of America (BAC) Target Cut at Morgan Stanley on Earnings Revisions Photo by NeONBRAND on Unsplash On December 12, Morgan Stanley reduced its price target on Bank of America Corporation (NYSE:BAC) to $68 from $70. The firm maintained an Overweight rating. The firm also adjusted its earnings expectations, cutting its fourth-quarter EPS estimate by 4% and lowering its 2027 forecast by 2.5%. T ...
Why Robot ETFs Are Poised to Outperform for the Next 5 Years
The Motley Fool· 2025-12-16 19:35
Robot ETFs can electrify your portfolio's gains thanks to their focus on AI chipmakers and physical AI opportunities.Artificial intelligence (AI) has been the defining trend for the stock market. Some AI stocks have rocketed tenfold within five years, and AI exchange-traded funds (ETFs) have been some of the market's top-performing funds.However, the next big winners may be robot stocks and ETFs. These funds also ride AI tailwinds but focus on physical AI. Humanoid robots, drones, and AI-powered surgical to ...
Merck (MRK) Price Target Lifted at Morgan Stanley as Biopharma Outlook Improves
Yahoo Finance· 2025-12-16 19:34
Merck & Co., Inc. (NYSE:MRK) is included among the 15 Best Blue-Chip Stocks with Growing Dividends. Merck (MRK) Price Target Lifted at Morgan Stanley as Biopharma Outlook Improves Photo by Annie Spratt on Unsplash On December 12, Morgan Stanley lifted its price target on Merck & Co., Inc. (NYSE:MRK) to $102 from $100. The firm kept an Equal Weight rating on the stock. In its 2026 outlook for the biopharma space, the firm said many of the policy concerns that weighed on the sector this year are likely to ...
BANX: Continuing To Deliver Solid Results With ~8% Distribution Yield
Seeking Alpha· 2025-12-16 19:34
To see all that our exclusive membership has to offer, sign up for a free trial by clicking on the button below!At the CEF/ETF Income Laboratory , we manage closed-end fund ("CEF") and exchange-traded fund ("ETF") portfolios targeting safe and reliable ~8% yields to make income investing easy for you. Check out what our members have to say about our service.ArrowMark Financial Corp. ( BANX ) has continued to perform well since our last update, when we were going through the April tariff announcement volatil ...
Investing Pros Feel Good About Stocks These Days. That Might Not Be a Good Thing.
Yahoo Finance· 2025-12-16 19:33
ablokhin / Getty Images Global fund managers are more bullish than they've been in years by many measures, according to a recent BofA suvery. Key Takeaways Bank of America's Bull & Bear Indictor rose last week to within a tenth of a point from flashing "sell," a sign that high expectations and aggressive investor positioning could pressure stocks in the coming months. The indicator has sent two sell signals this year, but neither preceded a prolonged stock slump. Professional money managers are fee ...
Tom Lee Predicts 10-15% Downside For Stocks In Early 2026: Here Is Why The Ethereum Bull Sees Crypto's 'Best Years' Ahead
Yahoo Finance· 2025-12-16 19:32
Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. Wall Street analyst Tom Lee predicted on Monday a bearish first half for financial markets in 2026, but expects it to “come back in force” eventually. Lee Expects Market To ‘Come Back In Force’ In 2026 Lee, who chairs BitMine Immersion Technologies Inc. (NYSE:BMNR), said that 2026 could mirror 2025, a year marked by an early bear market shifting to a bull run later on. This assessment rang true for equit ...